⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NTRA News
Natera, Inc. Common Stock
INTERACT Supports Updated NCCN Guidelines that Expand Access to Appropriate Hereditary Cancer Genetic Testing
prnewswire.com
AMGN
ILMN
MYGN
NTRA
DGX
Chronic Myeloid Leukemia Clinical Trial Pipeline Appears Robust With 25+ Key Pharma Companies Actively Working in the Domain | DelveInsight
globenewswire.com
TLRY
TAK
TNDM
NVS
BMY
PFE
INCY
JNJ
AZN
MRK
ABBV
CRSP
SCLX
RIGL
JAZZ
GILD
REGN
AMGN
BIIB
PTGX
EXAS
SNOW
SRPT
VRTX
BNTX
ALKS
RGEN
IMUX
ADPT
ATRC
CRNX
CYTK
DTIL
EXEL
FGEN
GALT
GNTX
GRFS
GSK
HRMY
IDXX
ILMN
INSM
IONS
IRWD
KODK
LAKE
LULU
LYFT
MAR
MDLZ
MELI
MIRM
MNKD
MRNA
MTCH
NBIX
NCLH
NEM
NTRA
NVCR
ODFL
OMER
ORGO
OTEX
PACB
PBYI
PCAR
PEGA
PERI
PETS
PLRX
PMVP
PPC
PRGS
PRTA
PSNL
PTN
PZZA
QGEN
QTRX
RARE
RCEL
RDHL
RLAY
RLGT
RMD
ROST
RRX
RYAAY
RYTM
SAN
SBAC
SBRA
SEIC
SIGA
SIRI
SITE
SLAB
SLGN
SMCI
SMMT
SNPS
SNY
SOFI
SONO
SPCE
SSYS
STNG
STRA
STRL
STX
SWKS
SYK
SYNA
TCOM
TDOC
TECK
TEVA
TFX
TGTX
TIGR
TRMB
TRVG
TTWO
TUSK
TXRH
ULTA
UMC
UNFI
UNH
URBN
UTHR
VEEV
VELO
VERU
VIVO
VKTX
VLRS
VNDA
VRSK
VSAT
VTGN
WDC
WEC
WERN
WGO
WIX
WMB
WST
WTW
WYNN
XOM
XPER
XPO
XRAY
YETI
YRD
YUM
ZBRA
ZLAB
ZYME
Breast Cancer Continues to Impact Communities; Fort Worth Rallies Together to Take Action at Susan G. Komen® MORE THAN PINK Walk
businesswire.com
BAC
NTRA
GH
LLY
NVS
Natera and Susan G. Komen® Announce National Partnership to Accelerate Progress Against Breast Cancer
businesswire.com
NTRA
Genetic Testing Market Size to Surge to USD 62.61 Billion by 2035 – SNS Insider
globenewswire.com
ILMN
MYGN
TMO
NTRA
GH
INV
ABT
DGX
LH
CLRS
Breast Cancer Continues to Impact Communities; Milwaukee Rallies Together to Take Action at Susan G. Komen® MORE THAN PINK Walk
businesswire.com
FOX
PEP
BAC
LLY
NVS
NTRA
Breast Cancer Continues to Impact Communities; Northwest Ohio Rallies Together to Take Action at Susan G. Komen ® Race for the Cure
businesswire.com
AMZN
LLY
GH
BNTX
BAC
NTRA
Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™
businesswire.com
NTRA
Cerebral Palsy Treatment (2026-2031) - Advances in Rehabilitation and Assistive Technologies Drive Market Growth
globenewswire.com
ABBV
ZBH
SYK
NTRA
TEVA
PFE
Form 8-K
sec.gov
NTRA